Past, present, and future: an overview of the microbiology of acute otitis media.

Document Type

Article

Publication Date

12-2005

Identifier

DOI: 10.3810/pgm.12.2005.suppl42.216

Abstract

Helpful new treatment guidelines offer physicians structure in diagnosing and treating patients who have uncomplicated acute otitis media (AOM). These guidelines should be weighed in light of the evolving microbiology of AOM pathogens. Physicians must be cognizant of the cyclical changes in bacteria as well as new vaccines and antibiotics best suited to address AOM. Although pneumococcal vaccines have helped, serotype shifts and bacterial resistance could work against current treatment practices. Physicians should understand causal organisms and treat patients appropriately to mitigate antibiotic resistance. New vaccines in development may offer additional reduction in AOM and drug resistant pneumococcus in the future.

Journal Title

Postgraduate medicine

Volume

118

Issue

6 Suppl Emerging

First Page

32

Last Page

33

MeSH Keywords

Acoustic Impedance Tests; Anti-Bacterial Agents; Child, Preschool; Haemophilus influenzae; Humans; Infant; Middle Ear Ventilation; Moraxella catarrhalis; Otitis Media; Otitis Media with Effusion; Pneumococcal Vaccines; Risk Factors; Streptococcus pneumoniae; Vaccines, Conjugate; beta-Lactamases

Keywords

Acoustic Impedance Tests; Anti-Bacterial Agents; Child, Preschool; Haemophilus influenzae; Humans; Infant; Middle Ear Ventilation; Moraxella catarrhalis; Otitis Media; Otitis Media with Effusion; Pneumococcal Vaccines; Risk Factors; Streptococcus pneumoniae; Vaccines, Conjugate; beta-Lactamases

Library Record

Share

COinS